"Sarcoma, Ewing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Descriptor ID |
D012512
|
| MeSH Number(s) |
C04.557.450.565.575.650.800 C04.557.450.795.620.800
|
| Concept/Terms |
Sarcoma, Ewing- Sarcoma, Ewing
- Sarcoma, Ewing's
- Sarcoma, Ewings
- Ewing's Sarcoma
- Ewings Sarcoma
- Ewing's Tumor
- Ewings Tumor
- Tumor, Ewing's
- Ewing Sarcoma
- Ewing Tumor
- Tumor, Ewing
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma, Ewing".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma, Ewing".
This graph shows the total number of publications written about "Sarcoma, Ewing" by people in this website by year, and whether "Sarcoma, Ewing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 2 | 3 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 2 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 5 | 0 | 5 |
| 2024 | 3 | 1 | 4 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma, Ewing" by people in Profiles.
-
A Unique Case of Gross Hematuria in a Patient With Ewing Sarcoma. J Pediatr Hematol Oncol. 2025 Apr 01; 47(3):140-143.
-
The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nat Commun. 2025 Feb 02; 16(1):1267.
-
Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer Foundation. Pract Radiat Oncol. 2025 Mar-Apr; 15(2):180-186.
-
Contemporary surgical management of osteosarcoma and Ewing sarcoma. Pediatr Blood Cancer. 2025 Apr; 72 Suppl 2:e31374.
-
Pediatric Ewing Sarcoma Presentation, Treatment, and Outcomes Across Sociodemographic Groups. J Surg Res. 2024 Nov; 303:322-331.
-
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board. Cancer. 2024 Dec 01; 130(23):4028-4039.
-
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. J Clin Oncol. 2024 Nov; 42(31):3725-3734.
-
Residential proximity to oil and gas developments and childhood cancer survival. Cancer. 2024 Nov 01; 130(21):3724-3733.
-
Superficial Neurocristic EWSR1::FLI1 Fusion Tumor: A Distinctive, Clinically Indolent, S100 Protein/SOX10-Positive Neoplasm. Mod Pathol. 2024 Aug; 37(8):100537.
-
Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.